Feruno 500mg Injection

Feruno 500mg Injection contains an active ingredient known as Iron (III) Isomaltoside. This medication falls under the category of anti-anemic medicines. It is utilized as an iron replacement therapy to address iron deficiency anemia in adults who cannot tolerate oral iron or have not had a favorable response to oral iron formulations. Furthermore, this treatment is applicable for individuals with chronic kidney disease undergoing dialysis who are unable to take oral iron supplements. Due to insufficient data regarding its safety and effectiveness, Feruno 500mg Injection is not advised for individuals under 18 years of age, including children and teenagers.

Feruno 500mg Injection should be avoided if you are allergic to Iron (III) Isomaltoside or any of the components present in the medication. This medicine should not be administered if the anemia is not due to iron deficiency (for instance, “hemolytic” anemia), if there is iron overload or impaired iron utilization, or if there is a history of severe allergic reactions to other injectable iron products and active liver disease.

Prior to receiving Feruno 500mg Injection, it is crucial to inform your healthcare provider if you have a history of medication allergies, systemic lupus erythematosus, rheumatoid arthritis, or severe asthma. Additionally, notify your doctor if you have eczema, other allergies, an active bacterial infection in your bloodstream, or diminished liver function.